Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.96 USD | -0.29% | -3.72% | +0.14% |
23/04 | Truist Raises Price Target on Bally's to $16 From $14, Keeps Buy Rating | MT |
15/04 | Trinity Health Files a Notice of Exempt Solicitation to Bally?s Corporation | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company has a low valuation given the cash flows generated by its activity.
Weaknesses
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Casinos & Gaming
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.14% | 564M | C- | ||
+7.14% | 33.01B | B | ||
+5.10% | 24.32B | C+ | ||
+22.35% | 20.52B | D | ||
-18.63% | 19.87B | B- | ||
-18.07% | 19.35B | A | ||
-1.52% | 16.62B | B- | ||
-4.07% | 9.51B | C- | ||
-21.91% | 7.92B | B- | ||
+6.70% | 7.13B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BALY Stock
- Ratings Bally's Corporation